Assessment and management of heart failure in patients with chronic kidney disease.
暂无分享,去创建一个
G. Pontone | L. Fusini | S. Mushtaq | G. Vezzoli | F. Monitillo | A. Baggiano | M. Simonini | A. Guaricci | M. Carella | P. Basile | Fabio Fazzari | Francesca Sturdà | Roberto Russo | Fulvio Bertandino | Marco Matteo Ciccone | Giuseppe Grandaliano | Francesco Pesce
[1] A. Timóteo,et al. Efficacy of peritoneal dialysis in patients with refractory congestive heart failure: a systematic review and meta-analysis , 2023, Heart Failure Reviews.
[2] G. Pontone,et al. Improvement of Left Ventricular Global Longitudinal Strain after 6-Month Therapy with GLP-1RAs Semaglutide and Dulaglutide in Type 2 Diabetes Mellitus: A Pilot Study , 2023, Journal of clinical medicine.
[3] Y. Zhang,et al. Association between serum klotho concentration and heart failure in adults, a cross-sectional study from NHANES 2007-2016. , 2022, International journal of cardiology.
[4] G. Parati,et al. Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC‐TIVE study, an Italian nationwide survey , 2022, European journal of heart failure.
[5] T. Mavrakanas,et al. Hydralazine–Isosorbide Dinitrate Use in Patients With End-Stage Kidney Disease on Dialysis , 2022, Kidney international reports.
[6] R. Vasan,et al. Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease. , 2022, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[7] G. Pontone,et al. Coronary-specific quantification of myocardial deformation by strain echocardiography may disclose the culprit vessel in patients with non-ST-segment elevation acute coronary syndrome , 2022, European heart journal open.
[8] M. Carneiro-Ramos,et al. Cardiorenal syndrome: long road between kidney and heart , 2022, Heart Failure Reviews.
[9] aguda y crónica,et al. Comments on the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2022, Revista espanola de cardiologia.
[10] J. McMurray,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2022, European journal of heart failure.
[11] N. Farré,et al. Peritoneal dialysis in heart failure: focus on kidney and ventricular dysfunction. , 2021, Reviews in cardiovascular medicine.
[12] W. van Biesen,et al. Free P-Cresyl Sulfate Shows The Highest Association With Cardiovascular Outcome In Chronic Kidney Disease. , 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] T. Zeller,et al. Biomarkers for Heart Failure Prognosis: Proteins, Genetic Scores and Non-coding RNAs , 2020, Frontiers in Cardiovascular Medicine.
[14] H. Ueyama,et al. Systematic Review of the Association Between Worsening Renal Function and Mortality in Patients With Acute Decompensated Heart Failure , 2020, Kidney international reports.
[15] David W. Johnson,et al. Peritoneal Dialysis-Related Infection Rates and Outcomes: Results From the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). , 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] Spiros C. Denaxas,et al. Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure , 2020, Nature Communications.
[17] D. Andreini,et al. Multimodality imaging of left atrium in patients with atrial fibrillation. , 2019, Journal of cardiovascular computed tomography.
[18] H. Tighiouart,et al. Acute declines in estimated glomerular filtration rate on enalapril and mortality and cardiovascular outcomes in patients with heart failure with reduced ejection fraction. , 2019, Kidney international.
[19] Mira-Lynn Chavanon,et al. Early NT-proBNP and MR-proANP associated with QoL 1 year after acutely decompensated heart failure: secondary analysis from the MOLITOR trial. , 2019, Biomarkers in medicine.
[20] Christopher L. Roy,et al. 2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure: A Report of the American College of Cardiology Solution Set Oversight Committee. , 2019, Journal of the American College of Cardiology.
[21] J. Bargman,et al. Defining the role of peritoneal dialysis in management of congestive heart failure , 2019, Expert review of cardiovascular therapy.
[22] M. Emdin,et al. The analysis of left atrial function predicts the severity of functional impairment in chronic heart failure: The FLASH multicenter study. , 2019, International journal of cardiology.
[23] S. Niemczyk,et al. Peritoneal Ultrafiltration in the Long-Term Treatment of Chronic Heart Failure Refractory to Pharmacological Therapy , 2019, Front. Physiol..
[24] A. Remppis,et al. Peritoneal dialysis as therapeutic option in heart failure patients , 2019, ESC heart failure.
[25] P. Roberts,et al. Leadless Pacemaker Implantation in Hemodialysis Patients: Experience With the Micra Transcatheter Pacemaker. , 2019, JACC. Clinical electrophysiology.
[26] M. Wong,et al. Leadless Pacing in Hemodialysis Patients. , 2019, JACC. Clinical electrophysiology.
[27] M. Klintschar,et al. Fibroblast growth factor 23 is induced by an activated renin–angiotensin–aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[28] Xiaobin Han,et al. Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II , 2018, Scientific Reports.
[29] Dylan L. Steen,et al. Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial , 2018, JAMA cardiology.
[30] M. James,et al. Gadolinium-Based Contrast Agents in Kidney Disease: Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists , 2018, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.
[31] Wojciech Zareba,et al. Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference , 2018, European heart journal.
[32] G. Filippatos,et al. Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney disease , 2018, ESC heart failure.
[33] L. Lund,et al. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid‐range, and reduced ejection fraction , 2017, European journal of heart failure.
[34] D. Andreini,et al. Additional value of inflammatory biomarkers and carotid artery disease in prediction of significant coronary artery disease as assessed by coronary computed tomography angiography , 2017, European heart journal cardiovascular Imaging.
[35] I. Skoularigis,et al. Left atrial volume index in patients with heart failure and severely impaired left ventricular systolic function: the role of established echocardiographic parameters, circulating cystatin C and galectin-3 , 2017, Therapeutic advances in cardiovascular disease.
[36] G. Pontone,et al. Effect of Coronary Revascularization on the Prognostic Value of Stress Myocardial Contrast Wall Motion and Perfusion Imaging , 2017, Journal of the American Heart Association.
[37] Masaya Takahashi,et al. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy. , 2017, Kidney international.
[38] Luis M. Ruilope,et al. Renin-angiotensin system blockade: Finerenone. , 2017, Nephrologie & therapeutique.
[39] David W. Johnson,et al. Cardiac biomarkers in dialysis , 2016, AIMS Genetics.
[40] K. Aonuma,et al. Clinical Implications of Intrarenal Hemodynamic Evaluation by Doppler Ultrasonography in Heart Failure. , 2016, JACC. Heart failure.
[41] G. Filippatos,et al. Reframing the association and significance of co‐morbidities in heart failure , 2016, European journal of heart failure.
[42] I. Komuro,et al. Utility of Cystatin C for Estimating Glomerular Filtration Rate in Patients With Muscular Dystrophy. , 2016, International heart journal.
[43] N. Hassanin,et al. Early Detection of Subclinical Uremic Cardiomyopathy Using Two‐Dimensional Speckle Tracking Echocardiography , 2016, Echocardiography.
[44] F. Gaita,et al. Prognostic incremental role of right ventricular function in acute decompensation of advanced chronic heart failure , 2016, European journal of heart failure.
[45] S. Kutalek,et al. Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients on hemodialysis , 2016, Journal of Interventional Cardiac Electrophysiology.
[46] C. Parikh,et al. Amino-Terminal Pro-B-Type Natriuretic Peptide for Diagnosis and Prognosis in Patients With Renal Dysfunction: A Systematic Review and Meta-Analysis. , 2015, JACC. Heart failure.
[47] D. Freimark,et al. Inflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal Dialysis , 2015, BioMed research international.
[48] J. Kautzner,et al. Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic Heart Failure. , 2015, JACC. Heart failure.
[49] S. Rex,et al. Noninvasive estimation of left atrial pressure with transesophageal echocardiography , 2015, Annals of cardiac anaesthesia.
[50] K. Damman,et al. The kidney in heart failure: an update. , 2015, European heart journal.
[51] N. Abidin,et al. Cardiac imaging in patients with chronic kidney disease , 2015, Nature Reviews Nephrology.
[52] J. McMurray,et al. Terminology and definition of changes renal function in heart failure. , 2014, European heart journal.
[53] P. Ponikowski,et al. Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome—an analysis from RELAX-AHF , 2014, European journal of heart failure.
[54] C. O'connor,et al. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. , 2014, European heart journal.
[55] S. Wicky,et al. The Impact of Transvenous Cardiac Devices on Vascular Access Patency in Hemodialysis Patients , 2013, Seminars in dialysis.
[56] K. Swedberg,et al. The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT , 2013, European journal of heart failure.
[57] M. Rich,et al. Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial. , 2013, International journal of cardiology.
[58] Satoshi Okayama,et al. Prognostic value of B-type natriuretic peptide and its amino-terminal proBNP fragment for cardiovascular events with stratification by renal function. , 2013, Journal of cardiology.
[59] Yukihito Sato. Diagnostic and prognostic property of NT-proBNP in patients with renal dysfunction. , 2013, Journal of cardiology.
[60] Azra Bihorac,et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury , 2013, Critical Care.
[61] R. Leano,et al. Hydroxyurea is associated with lower prevalence of albuminuria in adults with sickle cell disease. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[62] A. Khwaja. KDIGO Clinical Practice Guidelines for Acute Kidney Injury , 2012, Nephron Clinical Practice.
[63] K. Leunissen,et al. Prospective study on clinical effects of renal replacement therapy in treatment-resistant congestive heart failure. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[64] E. Núñez,et al. Continuous ambulatory peritoneal dialysis as a therapeutic alternative in patients with advanced congestive heart failure , 2012, European journal of heart failure.
[65] S. Aker,et al. Peritoneal dialysis relieves clinical symptoms and is well tolerated in patients with refractory heart failure and chronic kidney disease , 2012, European journal of heart failure.
[66] C. Ronco,et al. Cardio-renal syndromes: a systematic approach for consensus definition and classification , 2012, Heart Failure Reviews.
[67] Thomas H. Marwick,et al. Use and Limitations of E/e' to Assess Left Ventricular Filling Pressure by Echocardiography , 2011, Journal of cardiovascular ultrasound.
[68] H. Halperin,et al. End‐Stage Renal Disease Predicts Complications in Pacemaker and ICD Implants , 2011, Journal of cardiovascular electrophysiology.
[69] G. Lip,et al. Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function. , 2011, Journal of the American College of Cardiology.
[70] Bertram Pitt,et al. Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial , 2011, European heart journal.
[71] J. McMurray,et al. Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS‐HF) , 2010, European journal of heart failure.
[72] J. Struck,et al. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death. , 2009, Journal of the American College of Cardiology.
[73] B. Fagerberg,et al. The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF). , 2009, Journal of cardiac failure.
[74] D. Kaye,et al. Tricuspid regurgitation contributes to renal dysfunction in patients with heart failure. , 2008, Journal of cardiac failure.
[75] W. Mullens,et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. , 2008, Journal of the American College of Cardiology.
[76] G. Fonarow,et al. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. , 2007, Journal of cardiac failure.
[77] Simon C. Potter,et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.
[78] J. Cohn,et al. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data. , 2006, Clinical chemistry.
[79] M. Nieminen,et al. Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP. , 2006, European heart journal.
[80] K. Adams,et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). , 2005, American heart journal.
[81] G. Bakris,et al. beta-Blocker use in long-term dialysis patients: association with hospitalized heart failure and mortality. , 2004, Archives of internal medicine.
[82] J. Craft. Eplerenone (Inspra), a New Aldosterone Antagonist for the Treatment of Systemic Hypertension and Heart Failure , 2004, Proceedings.
[83] G. Eknoyan,et al. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.
[84] P. Golino,et al. Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. , 2003, Journal of the American College of Cardiology.
[85] J. Hollander,et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[86] M. Raftery,et al. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis. , 1994, Kidney international.
[87] K. Nolph,et al. [Continuous ambulatory peritoneal dialysis]. , 1978, Polskie Archiwum Medycyny Wewnetrznej.
[88] Akshay S. Desai,et al. Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF Trial , 2017, JAMA cardiology.
[89] J. Cleland,et al. IVC diameter in patients with chronic heart failure: relationships and prognostic significance. , 2013, JACC. Cardiovascular imaging.
[90] G. Plosker,et al. Icodextrin , 2012, Drugs.
[91] G. Fonarow,et al. Epidemiology and risk profile of heart failure , 2011, Nature Reviews Cardiology.
[92] D. Madigan,et al. Detection of Spironolactone-Associated Hyperkalaemia Following the Randomized Aldactone Evaluation Study (RALES) , 2007, Drug safety.